In this article, We will analyze BERYL DRUGS to build a profitable portfolio, and also pivot technical analysis..
52 WEEK HIGH AND 52 WEEK LOW
BERYL DRUGS 52 week high is 14.83 and 52 week low is 5.18 .
EPS
BERYL DRUGS earning per share is 0.67
VWAP
VWAP level is 12.17 based on the closing price. This is on hourly chart
Revenue
The BERYL DRUGS Net Revenue from last quarter is 4.61 crore.
FACE VALUE
The BERYL DRUGS Face value is 10.00.
Market Capital
The BERYL DRUGS Full Market Capital is6.34crore.
INDUSTRY
BERYL DRUGS is listed under Pharmaceuticals industry.
Index
BERYL DRUGS is part of the XIndex Group.
